Blood pressure | Adherent | Any non-adherent | Complete non-adherent | Beta (SE)* | p Value* | Beta (SE)† | p Value† |
---|---|---|---|---|---|---|---|
Clinic SBP‡ | 161±24.0 | 170±24.7 | 177±28.5 | −9 (3.7) | 0.0209 | −18 (5.4) | 0.0010 |
Clinic DBP‡ | 90±14.4 | 100±19.1 | 107±18.3 | −9 (2.4) | 0.0003 | −16 (3.5) | 1.0×10−5 |
24 h daytime SBP§ | 152±19.8 | 159±21.1 | 165±17.3 | −6 (4.2) | 0.1814 | −14 (5.5) | 0.0146 |
24 h daytime DBP§ | 86±13.1 | 94±13.0 | 100±9.8 | −6 (2.6) | 0.0286 | −11 (3.2) | 0.0006 |
*Difference between adherence and any non-adherence (both partial and complete) after adjustment for age, sex, ethnicity and clinical category.
†Difference between adherence and complete non-adherence after adjustment for age, sex, ethnicity and clinical category.
‡Systolic blood pressure (SBP) and diastolic blood pressure (DBP)—information available for 152 adherent, 52 any non-adherent and 21 completely non-adherent patients.
§24 h daytime SBP and DBP—information available for 121 adherent, 26 any non-adherent and 15 completely non-adherent patients, data in columns 2–4 are means and SDs of absolute blood pressure values recorded by clinic measurements and 24 h ambulatory blood pressure monitoring. Beta—β-coefficient, p value—level of statistical significance; all from adjusted linear regression models with blood pressure as dependent quantitative variable and age, sex, ethnicity and clinical category (new referrals, follow-up patients, referrals for renal denervation) as well as non-adherence to antihypertensive treatment as independent parameters included in the model.